Buy Aurobindo Pharma, Just Dial: Hemant Thukral

Hemant Thukral of Aditya Birla Money told CNBC-TV18, "We have selected two midcap stocks which have seen good open interest addition - one is pharmaceutical midcap - Aurobindo Pharma. We have seen that when pharma stocks saw rally, it has slightly been underperformer but we saw good open interest addition of 11 percent. However, for me the important thing was the way 700 Put writers got active.""So, suggesting now the base which the stock is trying to break out from Rs 693-695 will act as a support, so that can be a stop loss. I think the stock has potential to go up to Rs 730-735 in the immediate short-term," he said."The second stock that we have chosen today is slightly more volatile, it's Just Dial. The stock has seen good amount of open interest addition, 11 percent open interest (OI) been added up. The important thing is the way the cash volume moved up, 43 lakh shares got traded. Its 5-day average is only 20 lakh shares, so double the quantity got traded in cash. The stock technically has also moved up above Rs 400 mark. So, we will keep a stop loss of Rs 391. It's a slightly tight stop loss because it is a volatile counter," he added.